I n clinical practice, global left ventricular (LV) systolic function is typically assessed by means of LV volumes and ejection fraction (EF), most frequently measured using echocardiography. However, in metabolic diseases, 1 known 2 or suspected cardiomyopathies, 3 or cardiotoxicity, 4 the evaluation of global systolic chamber function sometimes entails more sensitive and robust indices than EF. In epidemiological research, alternative noninvasive methods derived from Doppler echocardiography have also proved to be more sensitive than EF to detect subtle abnormalities of systolic function. 5-7 Consequently, several indices have been implemented based on the analysis of myocardial deformation (eg, global systolic myocardial strain or strain rate [SR]), 8 of chamber fluid dynamics (eg, intraventricular pressure gradients), 9 and on single-beat approximations to the end-systolic pressure-volume relationship (ESPVR). 10,11 Importantly, however, whether these methods account for true global chamber systolic function in the clinical setting has not been established clearly. Also, their performance in disease conditions associated with an abnormal systolic load has not been studied specifically.
Invasive indices based on the pressure-volume relationship are the most reliable reference standards to evaluate global LV systolic chamber function in the intact heart. 12 Therefore, the pressure-volume loop method has been used to validate most Doppler echocardiographic indices of systolic function in animal experiments. However, most of these validation studies have relied on repeated measures experiments in a small number of animals, focusing on acute load and inotropic interventions, frequently in normal ventricles. [8] [9] [10] 13 Extrapolating the results of these studies to compare differences in baseline systolic chamber function among patients may be misleading, particularly in the presence of abnormal load confounders. 14 The objectives of the present study were twofold: (1) to validate Doppler echocardiographic indices of systolic chamber function against LV maximal elastance (E max ) obtained from the ESPVR, and (2) to assess the influence of baseline preload and afterload confounders on noninvasive indices.
Methods

Patients
The study protocol was approved by the local institutional review board, and all subjects provided written informed consent. Twentyseven patients in sinus rhythm undergoing left heart catheterization were included. Indications for the catheterization procedure were ruling out coronary artery disease in: (1) patients with chest pain of unknown cause with normal EF (n=10); (2) patients with dilated cardiomyopathy (n=8); and (3) patients with cirrhosis candidates for liver transplantation with >2 cardiovascular risk factors (n=9). Patients with cirrhosis were specifically selected because of their characteristically abnormal preload and afterload. 15 Clinical and demographic data of patients are shown in Table 1 . No patient underwent coronary revascularization in the same procedure.
Signal Acquisition Protocol and Pressure-Volume Data Analysis
All catheterization procedures were performed by the femoral approach. A high-fidelity pressure-conductance 7F pig-tail catheter (CD-Leycom, The Netherlands) was placed inside the LV, connected to a dual-field conductance processor (CD-Leycom CFL-512), and calibrated using the hypertonic saline method. 16 An occlusion balloon (PTS404, NuMED Canada, Inc) was placed at the junction of the inferior vena cava and the right atrium. A Swan-Ganz catheter was used to measure pulmonary pressures, thermodilution cardiac output, and stroke volume. Systemic vascular resistance was calculated from invasive recordings of systemic blood pressure. All signals were digitized at 250 Hz. Pressure and volume signals were acquired at end-expiratory apnea during transient caval occlusion. To minimize reflex activation, we obtain pressure-volume loops only during the first 5 to 6 seconds after balloon occlusion. This acquisition process was repeated 3× to 5× in each patient, waiting for stabilization periods of 5 minutes. E max , defined as the slope of the ESPVR, was calculated using the iterative regression method ( Figure 1A ). 16 Effective arterial elastance (E a ) was measured from the pressure-volume loops as the ratio of end-systolic pressure (P es ) to stroke volume. 17 End-systolic wall stress (σ) was calculated from the pressure-volume measurements under the assumption of a thickwalled sphere using the following formula: 18, 19 
The volume of the LV wall (V w ) was obtained as the LV mass divided by myocardial density. In turn, LV mass was measured from 3-dimensional (3D) echocardiographic sequences and calibrated (Data Supplement).
From the intraventricular high-fidelity pressure signals, we extracted the peak LV pressure, end-diastolic LV pressure, and the maximum of the first time derivative of LV pressure (dP/dt max ).
Echocardiographic Image Acquisition and Analysis
To avoid biological variability, all signals and images for measuring invasive and noninvasive indices of global systolic function were obtained simultaneously during the catheterization procedure. Broadband 2.0 to 4.0 MHz transducers were used either on a Vivid-7 or on a Vivid-9 (General Electric Healthcare) system. Echocardiographic acquisitions were performed 5 minutes after completing the set of caval occlusions to define the ESPVR. Invasive tracings and images were synchronized by cross correlation of a signal connected to the ultrasound scanner and the hemodynamic signal acquisition system. 20, 21 LV volumes and EF were calculated using biplane Simpson method. 22 Midwall fractional shortening was calculated based on 2D measurements. Global longitudinal and circumferential strain and SR were measured using commercial speckle-tracking software (EchoPac v.110.1.2; General Electric) from the 4-chamber view and short-chamber views, respectively ( Figure 1B) .
Color Doppler M-mode images were obtained and processed from the 5-chamber view and processed to obtain noninvasive indices derived from the intraventricular pressure difference waveform (Data Supplement). 23 Using custom software, Doppler velocities are first decoded from the raw velocity coded data stored in the DICOM (Digital Imaging and Communications in Medicine) images via conversion to hierarchical data format. 24 Then, raw velocities are dealiased, filtered, and differentiated using smoothing splines. The 1D Euler momentum equation is solved to obtain the M-mode distributions of the intraventricular pressure gradients along a center ejection flow streamline ( Figure 1C ). 23 Finally, the pressure gradient distributions are integrated to obtain the pressure difference waveform between the LV apex and the outflow tract ( Figure 1C ). 9 Ejection intraventricular pressure difference (EIVPD) measurements have been validated previously in vivo, 9 and clinical reproducibility in our laboratory has been reported. 20, 21 Noninvasive estimations of maximal elastance were obtained using 2 previously reported single-beat methods that do not require preload manipulation. 10, 11 Method 1 (E max-sb1 ) requires an empirical estimation of normalized population-averaged elastance at the onset of ejection (E Nd_avg ). 10 This normalized value is fitted by a 7-degree polynomial to the ratio of the pre-ejection to the total systolic ejection periods Mean±SD; n (%). ACEI indicates angiotensin-converting enzyme inhibitor; and ARBs, angiotensin receptor blockers. B, Circumferential (blue) and longitudinal (red) global strain and strain rate tracings obtained from 2-dimensional echocardiographic images using speckle-tracking software; the peak global strain and strain rate are depicted (*). C, Intraventricular pressure gradient maps obtained by postprocessing color Doppler M-mode images (top row) and pressure difference waveforms between the apex and the outflow tract (bottom row). The peak ejection intraventricular pressure difference is depicted in each curve (• ). measured from Doppler spectrograms. 10 From this averaged value, normalized elastance at ejection onset (E Nd_est ) is then calculated from diastolic and end-systolic pressures (P d and P es , respectively) as follows:
and E max-sb1 is obtained from systolic blood pressure P s as follows:
For method 2, single-beat elastance is measured assuming a volume intercept of 0 mm Hg as follows 11 :
To separate the error related to the inaccuracy of the noninvasive measurements from the error of the single-beat methods themself, E max-sb1 and E max-sb2 were also calculated using conductance-derived volumes and invasive measurements of P d and P es .
To measure LV mass from LV real-time full-volume 3D acquisitions, a second echocardiographic examination was performed in the echocardiography laboratory in the same day of the invasive procedure. All ultrasound measurements other than LV mass were obtained in the catheterization laboratory.
Statistical Analysis
Differences between hemodynamic data between patient groups (chest pain, dilated cardiomyopathy, and patients with cirrhosis) were assessed by ANOVA followed by Dunnet contrasts against the chest pain group. The correlation between noninvasive indices of systolic function and E max was analyzed using the Pearson correlation coefficient (R) and corrected to avoid overfitting by bootstrap validation of 1000 repetitions (R boot ). Different regression slopes between E max and noninvasive indices of systolic function were assessed by ANCOVA analysis.
Because neither preload nor afterload can be unequivocally characterized by a single hemodynamic measurement, 25 we integrated physiologically related variables into unique synthetic surrogates of load using data reduction strategies. 26 This approach of variable clustering simplifies regression modeling because it avoids trying to separate the effects of factors that are measuring the same phenomenon. 26 Thus, we calculated a synthetic index of preload as the first principal component of the principal component analysis (R software, version 3.0.1) based on the correlation matrix of LV enddiastolic pressure and LV end-diastolic volume. The correlation of the synthetic index with these 2 raw variables was R=0.82 for both. We obtained the synthetic index of afterload integrating σ, E a , and systemic vascular resistance using the same method. Correlation of these raw variables with the integrated afterload synthetic index was R=0.90, 0.97, and 0.95, respectively. The effects of load confounders were analyzed using multiple linear regression models in which the noninvasive index was entered as the dependent variable, E max as the independent variable, and LV mass, preload, and afterload as covariables. Standardized β-coefficients were used to compare the effects of individual predictors. Regression diagnostics (outlier exclusion, normality of residuals with constant variance, and lack of significant interactions and nonlinearities) were performed for all these regression models. We used principal component analysis with illustrative variables to visualize the autocorrelation among noninvasive indices and their relationship with E max , LV mass, and load. Values of P<0.05 were considered significant.
Results
Load and Hemodynamic Data
Patients with cirrhosis typically showed low afterload, with low values of systemic vascular resistance, E a , and σ ( Table 2) . Patients with dilated cardiomyopathy showed higher E a , and σ, and a trend toward higher systemic vascular resistance. There was no significant difference among groups in LV end-diastolic pressure. E max was reduced in patients with dilated cardiomyopathy but not in patients with cirrhosis. All noninvasive indices except E max-sb1 demonstrated impaired systolic chamber function in patients with dilated cardiomyopathy ( Table 2 ). Mean differences of most indices were not significantly different between the liver cirrhosis and the chest pain groups.
Correlation Between Noninvasive Indices and E max
Peak EIVPD showed the closest correlation with E max (Table 3; Figure 2 ). EF, midwall fractional shortening, and circumferential strain and SR showed a significant but weaker correlation with E max . E max-sb2 showed a weak correlation with E max , whereas E max-sb1 failed to correlate with E max . Even using volumes derived from the conductance catheter and invasive pressures in the single-beat formula, E max-sb1 did not correlate with E max (R=0.04). Slopes of the EIVPD-E max relationship were not different among patient groups (P=0.37).
Effect of Load and Mass on Indices of Systolic Function
The multiple regression analysis of the hemodynamic determinants of the noninvasive indices is shown in Table 4 . Peak EIVPD and global circumferential strain and SR were associated with systolic function (E max ) and were not significantly associated with LV mass, preload, or afterload. The magnitude of the association with E max was highest for peak EIVPD. Other indices, such as EF and midwall fractional shortening, were significantly associated with E max but also with load variables. E max-sb2 was only associated with LV mass, and E max-sb1 and global longitudinal strain and SR were influenced mostly by afterload (Table 4 ). Principal component analysis demonstrated that peak EIVPD was the variable most closely associated with E max , and that EF, longitudinal strain, SR, and E max-sb1 were associated with afterload ( Figure 3 ).
Discussion
This is the first clinical study to investigate the accuracy of ultrasound indices of systolic global chamber function by direct comparison with the invasive gold standard method derived from the pressure-volume relationship. Using a between-subjects design in a group of patients with heterogeneous inotropic states and loading conditions, Doppler-derived peak EIVPD showed the closest relationship with E max . Other noninvasive indices, such as EF, midwall fractional shortening, and circumferential strain and SR, showed a significant but weaker correlation with the reference method. Longitudinal strain and SR were closer to afterload than to systolic function in this population.
Effects of Load and Systolic Function on Strain and Strain Rate
The load dependence of strain and SR has been demonstrated in animal models, 27 but the inotropic sensitivity and relative effect of load on circumferential versus longitudinal strain are not well known in humans, and contradictory data have been published. A study in patients with normal or mildly impaired EF undergoing cardiac catheterization and acute loading interventions suggested that longitudinal strain is less sensitive to afterload than circumferential strain. 28 However, other studies indirectly suggest that circumferential strain may be more stable in patients with chronic abnormal afterload and secondary LV hypertrophy. In patients with aortic stenosis 29 and hypertension, 30 circumferential strain is preserved or even increased, 29 whereas longitudinal and radial strains are decreased. Moreover, in patients with aortic stenosis, the afterload relief caused by aortic valve replacement results in an acute increase of longitudinal strain. 29 The absence of changes in circumferential strain compared with longitudinal strain measurements has been interpreted frequently as a lower inotropic sensitivity of circumferential function. The results of our study suggest that this may be more likely related to a lower load dependency. Importantly, our study does not question the independent prognostic value of global longitudinal strain recently demonstrated in several conditions. 31, 32 As occurs with EF, the ability of longitudinal strain measurements to predict outcomes may be related to their capacity to amalgamate several variables related to integral pump performance.
EIVPD as an Index of Systolic Chamber Function
The inotropic sensitivity of the peak EIVPD is based on established fluid dynamic principles 33 and has been empirically confirmed in animals 34 as well as in patients undergoing pharmacological interventions. 21 The potential use of Dopplerderived EIVPD as an index of LV systolic chamber function was first demonstrated in an animal experimental study that showed a close correlation with reference indices based on the pressure-volume relationship. 9 The present study confirms that peak EIVPD closely correlates with E max in patients and supports its value as an index of LV systolic chamber function in the clinical setting. The relative load independence of peak EIVPD was also previously suggested by animal experimental data 9 and is confirmed in the present clinical study. EIVPD reaches its peak early during ejection, and this fact can probably explain the lower afterload dependence of this index in comparison with other ejection phase indices. We think that the closest relationship with E max and its relative load stability renders peak EIVPD as one of the most robust and sensitive indices of LV systolic function available using echocardiography.
Noninvasive Single-Beat Surrogates of Maximal Elastance
Combining LV volumes derived from echocardiography with peripheral arterial pressure has been proposed by several investigators as a surrogate method to noninvasively approximate the ESPVR. 10, 35 Our study demonstrates that these methods have important limitations related not only to the accuracy of the pressure and volume estimation but also to the single-beat approach. The simplest method based on the ratio of end-systolic pressure and end-systolic volume (E max-sb2 ) was more closely related to E max than the more complex method based on the estimation of the E Nd (E max-sb1 ). This result confirms that the estimation of E Nd is the main source of inaccuracy in single-beat calculations as previously demonstrated in experimental studies. 36 Some authors have assumed that E Nd is a constant value in humans in the presence or absence of cardiac disease. 35 However, in ischemic cardiomyopathy, it has been demonstrated that E Nd differs quantitatively from normal hearts in all phases of the heart cycle. 37 In addition, for noninvasive application, E Nd is estimated using a regression model derived from a small group of patients and based on noninvasive measurements of EF and arterial load. 10 Our results suggest that application of this regression model to heterogeneous groups of patients can be misleading.
Limitations
The study was designed to comprehensively validate noninvasive methods against reference standards of global baseline systolic chamber function. Because of the relatively small patient group, validation results may deserve confirmation in a larger sample. We did not perform repeated measurements within subjects to avoid further complexity in the pressurevolume loop catheterization procedure. Although a repeated measures design would have been useful for clarifying load dependence, this design has been reported previously by our group in the animal setting. 9 Our aim was to analyze the value of different noninvasive indices to account for LV systolic chamber function. The evaluation of myocardial contractility is a different issue that is, difficult to evaluate in vivo. It has been recognized that LV global systolic chamber function, and consequently E max , depends on myocardial contractility, muscle mass, and geometry. Only when mass and geometry are fixed, a shift of the ESPVR can be interpreted as a change in myocardial contractility. However, when evaluating patients with differences in LV mass and shape, as occurs in clinical practice and in the present study, ESPVR reflects changes of chamber properties but not necessarily of myocardial properties. Some authors have suggested normalizing E max for muscle mass and geometry. 38 However, important limitations have been recognized for E max normalization methods, particularly when relative wall thickness is abnormal. 39 We think the results of our multiple regression and principal component analyses, showing an irrelevant role of LV mass as a confounder, suggest that mass normalization would not have modified the major findings of our study. The method to obtain EIVPD is based on offline processing of digital color M-mode Doppler images using a custombuild algorithm that currently is not commercially available. This could limit the clinical application of this tool. However, computational requirements are low, and it could be easily incorporated into the analysis software of future ultrasound scanners to be used at bedside. Currently, strain and SR measurements are used increasingly in clinical practice and also require offline processing.
All noninvasive indices tested in the present study were obtained using Doppler echocardiography. Other modalities such as MRI provide a more accurate estimation of LV volumes, and tagging methods may also provide myocardial strain and SR measurements. However, our specific load-sensitivity results suggest that limitations of indices of systolic chamber function are modality independent.
Clinical Implications
Relevant conclusions about the physiopathological mechanisms involved in heart failure have been supported by noninvasive single-beat estimators of pressure-volume indices. Noninvasive single-beat estimations of E max have been used in the general population to analyze the effect of aging and sex on LV performance 5 and to compare patients with heart failure and normal EF with control subjects. 6 The weak or absent between-subject correlation demonstrated in the present study makes a critical review of these previous studies necessary and encourages the implementation of new Doppler-derived methods in the design of future large-scale studies.
Although EF is currently the pivotal index of systolic function in the clinical setting, under extreme or changing loading conditions, its applicability is limited, 13, 40 and the use of novel noninvasive indices that correlate with E max could add valuable diagnostic information. Peak EIVPD arises as a reliable index of systolic function that provides additional information not captured by other noninvasive indices. Examples of potentially relevant scenarios are situations of abnormal load, such as valve regurgitation, congenital heart disease, liver cirrhosis, systemic arteriovenous fistulae, or end-stage renal disease.
Conclusions
Noninvasive indices based on Doppler echocardiography have limited accuracy to characterize global LV systolic chamber function in the clinical setting. The Doppler-derived peak EIVPD best correlates with reference indices. This index should be preferred for assessing the state of global LV systolic chamber function, particularly in conditions associated with abnormal load.
